论文部分内容阅读
目的:对特布他林加布地奈德治疗哮喘的临床效果进行分析。方法:对2012年4月到2014年4月期间在我院接受治疗的60例哮喘患者进行临床研究,随机分为对照组和研究组,对对照组使用甲基强的松龙、喘定和特布他林进行治疗,对研究组使用特布他林加布地奈德进行治疗,观察比较两组患者的治疗效果。结果:研究组患者的治疗总有效率(86.7%)明显高于对照组患者(73.3%),差异存在统计学上的意义(P<0.05);研究组患者没有出现不良反应,对照组患者的不良反应发生率为6.7%,差异存在统计学上的意义(P<0.05)。结论:使用特布他林加布地奈德对哮喘患者进行治疗的临床疗效较好,患者的不良反应较少,具有一定的临床应用价值。
Objective: To analyze the clinical effect of terbutaline and budesonide in the treatment of asthma. Methods: Sixty asthmatic patients undergoing treatment in our hospital from April 2012 to April 2014 were randomly divided into control group and study group. Methylprednisolone, Terbutaline was used to treat the study group with terbutaline and budenidine, and the therapeutic effect of the two groups was observed and compared. Results: The total effective rate (86.7%) in the study group was significantly higher than that in the control group (73.3%), the difference was statistically significant (P <0.05). There was no adverse reaction in the study group and in the control group The incidence of adverse reactions was 6.7%, the difference was statistically significant (P <0.05). Conclusion: The clinical efficacy of terbutaline and budesonide for asthma patients is better, and patients have fewer adverse reactions, which has certain clinical value.